Çocuk Enfeksiyon Hastalıkları Polikliniğine Başvuran Enfeksiyöz Mononükleoz Tanısı Alan Hastaların Değerlendirilmesi

Öz

Amaç: Bu çalışmada enfeksiyöz mononükleoz tanısı alan çocukların klinik, laboratuvar ve radyolojik özelliklerinin incelenmesi amaçlanmıştır.Gereç ve Yöntem: Ocak 2015-Şubat 2016 tarihleri arasında, semptom ve klinik bulguları ile enfeksiyöz mononükleoz düşünülen ve anti-VCA IgM pozitif olan hastalar dâhil edildi. Çalışmaya bu kriterleri sağlayan 58 hasta alındı. Hasta dosyalarından vakaların yaş, cinsiyet, yakınma ve süresi, fizik muayene bulguları ve laboratuvar sonuçları kaydedildi. Bulgular: Vakaların 34’ü %58.6 erkek olup, erkek/kız oranı 1.4 idi. Hastaların yaş ortalaması 67.3±40.9 ay idi. Başvurularında hastaların çoğunun birden fazla yakınması mevcuttu. En sık belirtilen yakınma %72.4 boyunda şişlik olup bunu; ateş %51.7 ve boğaz ağrısı %44.8 izlemekteydi. Bu hastaların 45’inde %77,5 lenfadenopati mevcuttu. Bu bulguyu tonsiller hipertrofi 35, %60.3 , splenomegali 20, %34.4 , membranoz tonsillit 15, %25.9 , hepatomegali 12, %20.6 ve döküntü 10, %17.2 takip ediyordu. VCA IgM pozitifliği ile birlikte hastaların %17.2’sinde EBNA IgG ve %68.6’sında ise VCA IgG pozitifliği saptandı. Polikliniğimize başvurmadan önce hastaların 28’inin %48.2 bir antibiyotik tedavisi kullandığı öğrenildi. Hastaların 10’unda %17.3 döküntü olup, 3’ünde döküntünün antibiyotik kullanımı sonrası geliştiği belirlendi.Sonuç: Enfeksiyöz mononükleoz, klasik bulguların dışında farklı klinik bulgulara neden olabilir. Birçok viral ya da bakteriyel enfeksiyon tablosu ve malignitelerle karışabileceğinden ayırıcı tanıda düşünülmelidir

Anahtar Kelimeler

• Çocuk,enfeksiyöz mononükleoz,EBV

Evaluation of The Patients who Applied to the Pediatric Infectious Diseases Department and Received the Diagnosis of Infectious Mononucleosis

Öz

Objective: The aim of this study is to evaluate the clinical, laboratory and radiological findings of patients diagnosed with infectious mononucleosis.Material and Method: Fifty-eight patients who had been diagnosed with infectious mononucleosis according to symptoms and clinical findings in addition to anti viral capsid antigen immunoglobulin M anti-VCA IgM positive results between January 2015, and February 2016 were included in this study. Demographic and clinical data age, gender, presenting symptom and duration, physical examination findings and results of laboratory tests were gathered from patients’ files.Results: Thirty-four cases 58.6% were male and the male / female ratio was 1.4. The mean age of the children was 67.3±40.9 months. Most of the patients had more than one presenting symptom. The most common symptoms in order of decreasing frequency were swelling in the neck 72.4% , followed by fever 51.7% and sore throat 44.8% . Forty - five patients 77.5% had lymphadenopathy. The other findings were tonsillar hypertrophy n=35, 60.3% , splenomegaly, n=20, 34.4% , membranous tonsillitis n=15, 25.9% , hepatomegaly n=12, 20.6% and rash n=10, 17.2% . In addition to anti VCA-IgM positiviy; 17.2%of the patients also had EBNA IgG and 68.9 % had VCA IgG- positive results. Twenty- eight patients 48.2% were given antibiotherapy prior to admission in our outpatient clinic. Ten patients 17.3% had rash, and 3 5.1% of them it developed after previous antibiotherapy.Conclusion: Infectious mononucleosis may cause several clinical symptoms other than classical findings. Since it may be confused with manifestations of many viral or bacterial infection, and malignancies, it should be considered in differential diagnosis

Anahtar Kelimeler

• Child,infectious mononucleosis,EBV

Kaynakça

1. Dunmire SK, Hogquist KA, Balfour HH. Infectious Mononucleosis. Curr Top Microbiol Immunol 2015;390:211-40.
2. https://doi.org/10.1007/978-3-319-22822-8_9
3. Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med. 2010;362:1993-2000.
4. https://doi.org/10.1056/NEJMcp1001116
5. Behrman RE, Kliegman RM, Jenson HB. Nelson text- book of pediatrics. 19th edt. Philadelphia: Elsevier Saunders, 2011; 1110-4.
6. Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343:481-92.
7. https://doi.org/10.1056/NEJM200008173430707
8. Hess RD. Routine Epstein-Barr Virus diagnostics the laboratory perspective: Still challenging after 35 years. J Clin Microbiol. 2004;42:3381-7.

9. https://doi.org/10.1128/JCM.42.8.3381-3387.2004
10. Şereflican M, Yurttaş V, Seyhan S, Şereflican B, Dağlı M. Enfeksiyöz mononükleoz. www.entcase.org.
11. Sumaya CV, Ench Y. Epstein-Barr virus infectious mononucleosis in children. I. Clinical and general labo- ratory findings. Pediatrics 1985;75:1003-10.
12. Chan WC, Chiang AK, Chan KA, Lau AS. Epstein- Barr virus associated infectious mononucleosis in Chinese children. Pediatr Infect Dis J. 2013;22:974-8.
13. https://doi.org/10.1097/01.inf.0000095199.56025.96
14. Kılıç A, Yıldız İ, Beka H, et al. Çocuklarda farklı klinik tablolarla enfeksiyöz mononükleoz: 369 vakanın geri- ye dönük incelenmesi. Türk Ped Arş. 2012;47:189-92.
15. https://doi.org/10.4274/tpa.1664
16. Son KH, Shin MY. Clinical features of Epstein-Barr virus-associated infectious mononucleosis in hospitali- zed Korean children. Korean J Pediatr. 2011;54:409- 13.
17. https://doi.org/10.3345/kjp.2011.54.10.409
18. Çağlar M, Balcı YI, Polat A, Cevahir N, Çölgeçen Ş. Enfeksiyöz mononükleoz tanısı alan hastaların değerlendirilmesi. Pamukkale Tıp Dergisi 2014;3: 210-3.
19. Glynn FJ, Mackle T, Kinsella J. Upper airway obstruc- tion in infectious mononucleosis. Eur J Emerg Med. 2007;14:41-2.
20. https://doi.org/10.1097/01.mej.0000224431.36376.71
21. Womack J, Jimenez M. Common questions about infectious mononucleosis. Am Fam Physician. 2015;91:372-6.
22. Tsai MH, Hsu CY, Yen MH, et al. Epstein-Barr virüs- associated infectious mononucleosis and risk factor analysis for complications in hospitalized children. J Microbiol Immunol Infect. 2005;38:255-61.
23. Sevilla DW, El-Mallawany NK, Emmons FN, Alexander S, Bhagat G, Alobeid B. Spectrum of childhood Epstein-Barr virus-associated T-cell proliferations and bone marrow findings. Pediatr Dev Pathol. 2011;14:28- 37.
24. https://doi.org/10.2350/09-12-0753-OA.1
25. Cengiz AB, Cultu-Kantaroğlu O, Seçmeer G, Ceyhan M, Kara A, Gürgey A. Infectious mononucleosis in Turkish children. The Turkish Journal of Pediatrics, 2010;52:245-54.
26. Vetsika EK, Callan M. Infectious mononucleosis and Epstein-Barr virus. Expert Rev Mol Med. 2004;6:1- 16.
27. https://doi.org/10.1017/S1462399404008440
28. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med. 2004;350:1328-37.
29. https://doi.org/10.1056/NEJMra032015
30. Kofteridis DP, Koulentaki M, Valachis A, et al. Epstein Barr virus hepatitis. Eur J Intern Med. 2011;22:73-6.
31. https://doi.org/10.1016/j.ejim.2010.07.016
32. Arslan N, Akman H, Sayan M, Ozturk Y, Buyukgebiz B. Epstein-Barr virüs enfeksiyonuna ikincil gelişen hepatik yetmezlik. Çocuk Sağlığı ve Hastalıkları Dergisi 2003;46:47-9.
33. Balamuth NJ, Nichols KE, Paessler M, Teachey DT. Use of rituximab in conjunction with immunosuppres- sive chemotherapy as a novel therapy for Epstein Barrvirüs-associated hemophagocytic lymphohistiocy- tosis. J Pediatr Hematol Oncol. 2007;29:569-73.
34. https://doi.org/10.1097/MPH.0b013e3180f61be3